Neogen® to Participate in the 36th Annual Piper Sandler Healthcare Conference
Werte in diesem Artikel
LANSING, Mich., Nov. 27, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 36th Annual Piper Sandler Healthcare Conference in New York City on Wednesday, December 4, 2024.
John Adent, Neogen's President and Chief Executive Officer, will present at 11:00 a.m. Eastern Time.
To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Media Contact
Bill Waelke, Vice President, IR & Treasury
IR@Neogen.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-the-36th-annual-piper-sandler-healthcare-conference-302317060.html
SOURCE Neogen Corporation
Ausgewählte Hebelprodukte auf Neogen
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Neogen
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Neogen Corp.
Analysen zu Neogen Corp.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.2011 | Neogen neutral | J.J.B. Hilliard, W.L. Lyons, Inc. | |
| 22.07.2009 | Neogen buy | ROTH Capital Partners, LLC | |
| 20.03.2009 | Neogen buy | ROTH Capital Partners, LLC | |
| 07.01.2009 | Neogen Kursziel gesenkt | ROTH Capital Partners, LLC | |
| 26.09.2008 | Neogen neues Kursziel | ROTH Capital Partners, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.07.2009 | Neogen buy | ROTH Capital Partners, LLC | |
| 20.03.2009 | Neogen buy | ROTH Capital Partners, LLC | |
| 07.01.2009 | Neogen Kursziel gesenkt | ROTH Capital Partners, LLC | |
| 26.09.2008 | Neogen neues Kursziel | ROTH Capital Partners, LLC | |
| 04.01.2008 | Neogen neues Kursziel | ROTH Capital Partners, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.2011 | Neogen neutral | J.J.B. Hilliard, W.L. Lyons, Inc. |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogen Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen